Gustine, J. N. & Jones, D. Immunopathology of hyperinflammation in COVID-19. Am. J. Pathol. 191, 4–17 (2021).
Hu, B., Guo, H., Zhou, P. & Shi, Z. L. Traits of SARS-CoV-2 and COVID-19. Nat. Rev. Microbiol. 19, 141–154 (2021).
Lei, H. Y. et al. Potential results of SARS-CoV-2 on the gastrointestinal tract and liver. Biomed. Pharmacother. 133, 111064 (2021).
Bhatt, P. J. et al. Danger components and outcomes of hospitalized sufferers with extreme coronavirus illness 2019 (COVID-19) and secondary bloodstream infections: a multicenter case-control examine. Clin. Infect. Dis. 72, e995–e1003 (2020).
Zhu, X. et al. Co-infection with respiratory pathogens amongst COVID-2019 circumstances. Virus Res. 285, 198005 (2020).
Zhou, P. et al. Bacterial and fungal infections in COVID-19 sufferers: a matter of concern. Infect. Management Hosp. Epidemiol. 41, 1124–1125 (2020).
Yue, H. et al. The epidemiology and scientific traits of co-infection of SARS-CoV-2 and influenza viruses in sufferers throughout COVID-19 outbreak. J. Med. Virol. 92, 2870–2873 (2020).
Shen, Z. et al. Genomic variety of extreme acute respiratory syndrome–coronavirus 2 in sufferers with coronavirus illness 2019. Clin. Infect. Dis. 71, 713–720 (2020).
Bengoechea, J. A. & Bamford, C. G. SARS-CoV-2, bacterial co-infections, and AMR: the lethal trio in COVID-19?. EMBO Mol. Med. 12, e12560 (2020).
Lansbury, L., Lim, B., Baskaran, V. & Lim, W. S. Co-infections in individuals with COVID-19: a scientific overview and meta-analysis. J. Infect. 81, 266–275 (2020).
Lai, C.-C., Wang, C.-Y. & Hsueh, P.-R. Co-infections amongst sufferers with COVID-19: The necessity for mixture remedy with non-anti-SARS-CoV-2 brokers?. J. Microbiol. Immunol. Infect. 53, 505–512 (2020).
Bendala Estrada, A. D. et al. Insufficient use of antibiotics within the COVID-19 period: effectiveness of antibiotic remedy. BMC Infect. Dis. 21, 1144. https://doi.org/10.1186/s12879-021-06821-1 (2021).
Cuadrado-Payán, E. et al. SARS-CoV-2 and influenza virus co-infection. The Lancet 395, e84 (2020).
Saddique, A. et al. Emergence of co-infection of COVID-19 and dengue: a severe public well being menace. J. Infect. 81, e16–e18 (2020).
Kumar, D. R., Bhattacharya, D. B., Meena, D. V., Soneja, D. M. & Wig, D. N. COVID-19 and TB co-infection – ‘Crowning glory’ in good recipe to ‘severity’ or ‘dying’. J. Infect. 81, e39–e40 (2020).
Zhou, F. et al. Scientific course and threat components for mortality of grownup inpatients with COVID-19 in Wuhan, China: a retrospective cohort examine. Lancet 395, 1054–1062 (2020).
Llor, C. et al. Correlation between earlier antibiotic publicity and COVID-19 severity. A population-based cohort examine. Antibiotics (Basel) 10, 1364 (2021).
Harper, A. et al. Viral infections, the microbiome, and probiotics. Entrance. Cell. Infect. Microbiol. 10, 596166 (2020).
Gao, Z., Kang, Y., Yu, J. & Ren, L. Human pharyngeal microbiome could play a protecting position in respiratory tract infections. Genom. Proteom. Bioinformat. 12, 144–150 (2014).
Hornef, M. Pathogens, commensal symbionts, and pathobionts: discovery and practical results on the host. ILAR J. 56, 159–162 (2015).
McCullers, J. A. Insights into the interplay between influenza virus and pneumococcus. Clin. Microbiol. Rev. 19, 571–582 (2006).
Smith, W., Andrewes, C. H. & Laidlaw, P. P. A virus obtained from influenza sufferers. Lancet 222, 66–68 (1933).
Cartwright, Ok. et al. Influenza A and meningococcal illness. The Lancet 338, 554–557 (1991).
Murray, R. J. et al. Group-acquired pneumonia as a consequence of pandemic A (H1N1) 2009 influenzavirus and methicillin resistant Staphylococcus aureus co-infection. PLoS One 5, e8705 (2010).
Begum, M. M. et al. Evaluation of prescription sample of antibiotic medicine on sufferers affected by ENT an infection inside Dhaka Metropolis Bangladesh. Int. J. Fundamental Clin. Pharmacol. 6, 257–264 (2017).
de Steenhuijsen Piters, W. A. et al. Dysbiosis of higher respiratory tract microbiota in aged pneumonia sufferers. ISME J. 10, 97–108 (2016).
Troeger, C. et al. Estimates of the worldwide, regional, and nationwide morbidity, mortality, and aetiologies of diarrhoea in 195 nations: a scientific evaluation for the International Burden of Illness Research 2016. Lancet. Infect. Dis. 18, 1211–1228 (2018).
Naghavi, M. et al. International, regional, and nationwide age-sex particular mortality for 264 causes of dying, 1980–2016: a scientific evaluation for the International Burden of Illness Research 2016. The Lancet 390, 1151–1210 (2017).
Haque, M. Antimicrobial use, prescribing, and resistance in chosen ten chosen creating nations: a short overview. Asian J. Pharm. Clin. Res. 10, 37–45 (2017).
Sutradhar, Ok. B., Saha, A., Huda, N. H. & Uddin, R. Irrational use of antibiotics and antibiotic resistance in southern rural Bangladesh: views from each the physicians and sufferers. Annu. Res. Rev. Biol. 4, 1421–1430 (2014).
Nahar, P. et al. What contributes to inappropriate antibiotic shelling out amongst certified and unqualified healthcare suppliers in Bangladesh? A qualitative examine. BMC Well being Serv. Res. 20, 656 (2020).
Mahmud, A. S. M. et al. The genetic variant analyses of SARS-CoV-2 strains; circulating in Bangladesh. bioRxiv, (2020).
Saha, S. et al. Unbiased metagenomic sequencing for pediatric meningitis in Bangladesh reveals neuroinvasive chikungunya virus outbreak and different unrealized pathogens. mBio 10, e02877-02819 (2019).
Ramesh, A. et al. Metagenomic next-generation sequencing of samples from pediatric febrile sickness in Tororo, Uganda. PLoS One 14, e0218318 (2019).
Langmead, B. & Salzberg, S. L. Quick gapped-read alignment with Bowtie 2. Nat. Strategies 9, 357–359 (2012).
Salter, S. J. et al. Reagent and laboratory contamination can critically influence sequence-based microbiome analyses. BMC Biol. 12, 87 (2014).
Inouye, M. et al. SRST2: Fast genomic surveillance for public well being and hospital microbiology labs. Genome Med. 6, 90 (2014).
Solbiati, J. & Frias-Lopez, J. Metatranscriptome of the oral microbiome in well being and illness. J. Dent. Res. 97, 492–500 (2018).
Jie, Z. et al. The intestine microbiome in atherosclerotic heart problems. Nat. Commun. 8, 845 (2017).
Lepage, P. et al. A metagenomic perception into our intestine’s microbiome. Intestine 62, 146–158 (2013).
Ottman, N., Smidt, H., de Vos, W. M. & Belzer, C. The operate of our microbiota: Who’s on the market and what do they do?. Entrance. Cell. Infect. Microbiol. 2, 104 (2012).
Almeida, A. et al. A brand new genomic blueprint of the human intestine microbiota. Nature 568, 499–504 (2019).
Garcia-Vidal, C. et al. Incidence of co-infections and superinfections in hospitalized sufferers with COVID-19: a retrospective cohort examine. Clin. Microbiol. Infect. 27, 83–88 (2021).
Garazzino, S. et al. Multicentre Italian examine of SARS-CoV-2 an infection in youngsters and adolescents, preliminary knowledge as at 10 April 2020. Eurosurveillance 25, 2000600 (2020).
Martins-Filho, P. R., Tavares, C. S. S. & Santos, V. S. Components related to mortality in sufferers with COVID-19. A quantitative proof synthesis of scientific and laboratory knowledge. Eur. J. Intern. Med. 76, 97–99 (2020).
De Boeck, I. et al. Evaluating the wholesome nostril and nasopharynx microbiota reveals continuity in addition to niche-specificity. Entrance. Microbiol. 8, 2372 (2017).
Flynn, P. B. et al. Bactericidal efficacy of atmospheric stress non-thermal plasma (APNTP) in opposition to the ESKAPE pathogens. Int. J. Antimicrob. Brokers 46, 101–107 (2015).
Rawson, T. M. et al. Bacterial and fungal coinfection in people with coronavirus: a speedy overview to assist COVID-19 antimicrobial prescribing. Clin. Infect. Dis. 71, 2459–2468 (2020).
Qin, T. et al. Tremendous-dominant pathobiontic micro organism within the nasopharyngeal microbiota as causative brokers of secondary bacterial an infection in influenza sufferers. Emerg. Microb. Infect. 9, 605–615 (2020).
Lighthart, B. Mini-review of the focus variations discovered inthe alfresco atmospheric bacterial populations. Aerobiologia 16, 7–16 (2000).
Copeland, E. et al. Power rhinosinusitis: potential position of microbial dysbiosis and proposals for sampling websites. Entrance. Cell. Infect. Microbiol. 8, 57 (2018).
Hoque, M. N. et al. SARS-CoV-2 an infection reduces human nasopharyngeal commensal microbiome with inclusion of pathobionts. Sci. Rep. 11, 24042 (2021).
Saleem, H. G. M., Seers, C. A., Sabri, A. N. & Reynolds, E. C. Dental plaque micro organism with lowered susceptibility to chlorhexidine are multidrug resistant. BMC Microbiol. 16, 1–9 (2016).
Wong, L.-Y.R. & Perlman, S. Immune dysregulation and immunopathology induced by SARS-CoV-2 and associated coronaviruses—Are we our personal worst enemy?. Nat. Rev. Immunol. 22, 47–56 (2022).
Mostafa, H. H. et al. Metagenomic next-generation sequencing of nasopharyngeal specimens collected from confirmed and suspect COVID-19 sufferers. mBio 11, e01969 (2020).
Beck, J., Holloway, J. D. & Schwanghart, W. Undersampling and the measurement of beta variety. Strategies Ecol. Evol. 4, 370–382 (2013).
DeMuri, G. P., Gern, J. E., Eickhoff, J. C., Lynch, S. V. & Wald, E. R. Dynamics of bacterial colonization with Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis throughout symptomatic and asymptomatic viral higher respiratory tract an infection. Clin. Infect. Dis. 66, 1045–1053 (2018).
Barnes, C. E. & MacIntyre, C. R. Danger modelling the mortality influence of antimicrobial resistance in secondary pneumococcal pneumonia infections in the course of the 2009 influenza pandemic. Int. J. Infect. Dis. 85, 1–6 (2019).
Jia, L. et al. Mechanisms of extreme mortality-associated bacterial co-infections following influenza virus an infection. Entrance. Cell. Infect. Microbiol. 7, 338–338 (2017).
Chen, N. et al. Epidemiological and scientific traits of 99 circumstances of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive examine. The Lancet 395, 507–513 (2020).
Salminen, A. et al. Quantitative PCR evaluation of salivary pathogen burden in periodontitis. Entrance. Cell. Infect. Microbiol. 5, 69–69 (2015).
Dashper, S. G. et al. Temporal improvement of the oral microbiome and prediction of early childhood caries. Sci. Rep. 9, 19732 (2019).
Erb-Downward, J. R. et al. Evaluation of the lung microbiome within the “wholesome” smoker and in COPD. PLoS One 6, e16384–e16384 (2011).
Hilty, M. et al. Disordered microbial communities in asthmatic airways. PLoS One 5, e8578–e8578 (2010).
Beck, J. M., Younger, V. B. & Huffnagle, G. B. The microbiome of the lung. Trans. Res. 160, 258–266 (2012).
Di Conza, J. A. et al. β-lactamases produced by amoxicillin-clavulanate-resistant enterobacteria remoted in Buenos Aires, Argentina: a brand new blaTEM gene. Rev. Argent. Microbiol. 46, 210–217 (2014).
Biswas, M. et al. Self medicated antibiotics in Bangladesh: a cross-sectional well being survey carried out within the Rajshahi Metropolis. BMC Public Well being 14, 847 (2014).
Lucas, P. J. et al. Pathways to antibiotics in Bangladesh: a qualitative examine investigating how and when households entry drugs together with antibiotics for people or animals when they’re sick. PLoS One 14, e0225270–e0225270 (2019).
Hoque, R. et al. Tackling antimicrobial resistance in Bangladesh: a scoping overview of coverage and apply in human, animal and setting sectors. PLoS One 15, e0227947–e0227947 (2020).
Reinert, R. R. The antimicrobial resistance profile of Streptococcus pneumoniae. Clin. Microbiol. Infect. 15, 7–11 (2009).
